GlassScriptPhysician profile
James John Graham
NPI 1063831600
$2,133.07
in general payments reported to CMS, 2019-2025
26 companies · $432 in 2025
The $432 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $456 · 2020: $130 · 2021: $115 · 2022: $286 · 2023: $230 · 2024: $484 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,146.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $384.67 | 2021-2022 | |
| Abbvie INC. | $247.05 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $229.56 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $170.36 | 2019-2025 | Veozah |
| Exeltis, USA INC. | $163.75 | 2023-2025 | Slynd |
| Pfizer INC. | $143.04 | 2019-2024 | |
| Organon LLC | $137.60 | 2023-2025 | Nexplanon, Jada System |
| Hologic Sales and Service, LLC | $99.32 | 2020-2025 | Myosure Tissue Removal Device, Thinprep 2000 Processor, Aptima |
| Coloplast Corp | $93.01 | 2019 | |
| Mylan Pharmaceuticals INC. | $53.77 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $50.62 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $44.35 | 2019-2020 | |
| Agile Therapeutics, INC. | $40.34 | 2024 | Twirla |
| Optumhealth Care Solutions, LLC | $39.06 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Shield Therapeutics INC | $32.91 | 2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $27.15 | 2025 | |
| Millicent US INC | $24.06 | 2024 | Intrarosa, Femring |
| Gynesonics, INC. | $21.47 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sage Therapeutics, LLC | $18.90 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $18.90 | 2025 | Qelbree |
| Exact Sciences Corporation | $18.68 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $18.32 | 2019 | |
| Therapeuticsmd, INC. | $15.81 | 2022 | |
| Allergan, INC. | $14.91 | 2020 | |
| Coopersurgical, INC. | $14.39 | 2024 | Paragard T 380a |
| Amgen INC. | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.